Gastrointestinal Cancer
News
Cetuximab Fails First-Line in Gastric Cancer
Major Findings: Median progression-free survival was 4.4 vs.
News
Gefitinib Offers Palliative Care in Advanced Esophageal Cancer
Major Finding: Median overall survival was 3.73 months with gefitinib vs. 3.60 months with placebo (P = .285).Data Source: Data are from a phase...
Article
Cetuximab plus FOLFIRI in first-line treatment of KRAS mutation-negative, EGFR-positive metastatic colorectal cancer
News
FDA Approves Regorafenib for Metastatic Colorectal Cancer
News
Two Common Genetic Variants Linked to Barrett's Esophagus
Major Finding: The rs9257809 SNP on chromosome 6p21 and the rs9936833 SNP on chromosome 16q24 both were strongly associated with an increased risk...
News
Long-Term Follow-Up Warranted After Gastric MALT Lymphoma Remission
Major Finding: Of 120 participants, 96 (80%) achieved complete remission of gastric MALT lymphoma, and 80% of them (77/96) remained disease free....
News
Esophageal Cancers Reported After Radiofrequency Ablation
News
Ablation Cost Effective for High-Grade Dysplasia in Barrett's Esophagus
News
Robotic Device for Gastric Neoplasia Found Safe in Five Patients
Major Finding: Five patients who underwent endoscopic submucosal dissection of early-stage gastric neoplasia with the use of a novel robotic...
News
Upper GI Cancer Risk Elevated in AIDS
Major Finding: The risk of developing cancer of the esophagus and stomach is increased by 69% and 44%, respectively, in people with AIDS, compared...